(19)
(11) EP 1 355 659 A2

(12)

(88) Date of publication A3:
17.04.2003

(43) Date of publication:
29.10.2003 Bulletin 2003/44

(21) Application number: 02714757.8

(22) Date of filing: 18.01.2002
(51) International Patent Classification (IPC)7: A61K 38/18
(86) International application number:
PCT/US0201/666
(87) International publication number:
WO 0205/8718 (01.08.2002 Gazette 2002/31)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 26.01.2001 US 264457 P

(71) Applicant: Genetix Pharmaceuticals Inc.
Cambridge, MA 02139 (US)

(72) Inventors:
  • PAWLIUK, Robert
    Medford, MA 02155 (US)
  • LEBOULCH, Philippe
    Charlestown, MA 02129 (US)
  • Cao, Renhai.
    S-168 74 Stockholm (SE)
  • Cao, Yihai.
    S-168 59 Stockholm (SE)

(74) Representative: Kirkham, Nicholas Andrew et al
Graham Watt & Co.St. Botolph's House7-9 St. Botolph's Road
SevenoaksKent TN13 3AJ
SevenoaksKent TN13 3AJ (GB)

   


(54) USE OF COMPOSITIONS CONTAINING PDGF-BB FOR PROMOTING ANGIOGENESIS